GlassScriptPhysician profile
Susan Wong
NPI 1811051311
$2,274.59
in general payments reported to CMS, 2019-2025
14 companies · $608 in 2025
The $608 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $761 · 2020: $114 · 2022: $110 · 2023: $455 · 2024: $225 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $490.23 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $410.66 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $249.99 | 2025 | Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $151.19 | 2019 | |
| Alcon Vision LLC | $135.78 | 2022-2023 | Argos |
| Tarsus Pharmaceuticals, INC. | $120.65 | 2025 | Xdemvy |
| Dompe US, INC. | $119.86 | 2025 | Oxervate |
| Apellis Pharmaceuticals, INC. | $117.83 | 2025 | Syfovre |
| Sun Pharmaceutical Industries INC. | $114.30 | 2024 | |
| Rxsight INC | $111.02 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Abbvie INC. | $94.70 | 2023 | Durysta |
| Oyster Point Pharma, INC. | $89.08 | 2022 | |
| Carl Zeiss Meditec, INC. | $57.55 | 2019 | |
| Sanofi Pasteur INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.